en

PRODUCT DETAIL

Caprelsa 300 mg filmom obalené tablety

Code 32669
MA number EU/1/11/749/002
Product Form: tbl flm 30x300 mg (blis.PVC/PVDC/Al)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 44 - CYTOSTATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01E Protein kinase inhibitors
L01EX Other protein kinase inhibitors
L01EX04 Vandetanib
Shelf life: 48
Container: blister PVC/PVDC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 17.02.2012
Validity: 28.11.2027
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 02.12.2022
eu-flag.png sk-flag.png